INTERNATIONAL PATENT: SORRISO PHARMACEUTICALS, INC. FILES APPLICATION FOR "DOSAGES OF IL-23 AND TNF-ALPHA INHIBITORS FOR USE IN AUTOIMMUNE AND INFLAMMATORY DISORDERS"

GENEVA, April 17 -- SORRISO PHARMACEUTICALS, INC. (9295 S. 1300 E. #3Sandy, Utah 84094) filed a patent application (PCT/US2024/049834) for "DOSAGES OF IL-23 AND TNF-ALPHA INHIBITORS FOR USE IN AUTOIMMUNE AND INFLAMMATORY DISORDERS" on Oct 03, 2024. With publication no. WO/2025/076251, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DORSEY, Brian Talmadge (9295 S. 1300 E. #3Sandy, Utah 84094), SATTLER, Carlos A. (9295 S. 1300 E. #3Sandy, Utah 84094), BARBAT, Sara H. (9295 S. 1300 E. #3Sandy, Utah 84094), WEDEL, Pamela Chri...